News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,115 Results
Type
Article (67381)
Company Profile (428)
Press Release (618306)
Multimedia
Podcasts (104)
Webinars (14)
Section
Business (180071)
Career Advice (3216)
Deals (31960)
Drug Delivery (110)
Drug Development (82419)
Employer Resources (179)
FDA (15694)
Job Trends (14244)
News (317046)
Policy (30626)
Tag
Academia (2936)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (89)
Alliances (48696)
ALS (97)
Alzheimer's disease (1486)
Antibody-drug conjugate (ADC) (146)
Approvals (15665)
Artificial intelligence (278)
Autoimmune disease (28)
Automation (14)
Bankruptcy (306)
Best Places to Work (11374)
BIOSECURE Act (18)
Biosimilars (103)
Biotechnology (319)
Bladder cancer (84)
Brain cancer (30)
Breast cancer (298)
Cancer (2375)
Cardiovascular disease (191)
Career advice (2716)
Career pathing (33)
CAR-T (173)
Cell therapy (485)
Cervical cancer (19)
Clinical research (66349)
Collaboration (894)
Company closure (1)
Compensation (505)
Complete response letters (27)
COVID-19 (2697)
CRISPR (48)
C-suite (252)
Cystic fibrosis (107)
Data (2254)
Decentralized trials (2)
Denatured (32)
Depression (54)
Diabetes (281)
Diagnostics (6087)
Digital health (19)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (130)
Drug pricing (110)
Drug shortages (31)
Duchenne muscular dystrophy (101)
Earnings (67247)
Editorial (45)
Employer branding (23)
Employer resources (155)
Events (110631)
Executive appointments (720)
FDA (16967)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (785)
Gene editing (117)
Generative AI (27)
Gene therapy (356)
GLP-1 (783)
Government (4552)
Grass and pollen (5)
Guidances (61)
Healthcare (18956)
Huntington's disease (23)
IgA nephropathy (31)
Immunology and inflammation (139)
Indications (30)
Infectious disease (2838)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (99)
Interviews (627)
IPO (15251)
IRA (46)
Job creations (3326)
Job search strategy (2229)
Kidney cancer (10)
Labor market (36)
Layoffs (485)
Leadership (23)
Legal (6549)
Liver cancer (71)
Lung cancer (335)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (324)
MASH (72)
Medical device (12385)
Medtech (12389)
Mergers & acquisitions (17300)
Metabolic disorders (737)
Multiple sclerosis (83)
NASH (21)
Neurodegenerative disease (105)
Neuropsychiatric disorders (34)
Neuroscience (2069)
NextGen: Class of 2025 (6609)
Non-profit (4723)
Now hiring (33)
Obesity (392)
Opinion (265)
Ovarian cancer (77)
Pain (98)
Pancreatic cancer (80)
Parkinson's disease (155)
Partnered (22)
Patents (235)
Patient recruitment (111)
Peanut (49)
People (53256)
Pharmaceutical (83)
Pharmacy benefit managers (20)
Phase I (20785)
Phase II (29200)
Phase III (21730)
Pipeline (1231)
Policy (156)
Postmarket research (2712)
Preclinical (9389)
Press Release (71)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (425)
Real estate (5776)
Recruiting (72)
Regulatory (21701)
Reports (37)
Research institute (2627)
Resumes & cover letters (508)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (78)
Series A (138)
Series B (87)
Service/supplier (15)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (160)
Sponsored (34)
Startups (3486)
State (2)
Stomach cancer (16)
Supply chain (70)
Tariffs (39)
The Weekly (71)
Vaccines (724)
Venture capitalists (42)
Weight loss (273)
Women's health (33)
Worklife (20)
Date
Today (138)
Last 7 days (895)
Last 30 days (2657)
Last 365 days (33376)
2025 (10985)
2024 (35766)
2023 (40227)
2022 (51275)
2021 (55602)
2020 (53508)
2019 (46402)
2018 (35103)
2017 (32649)
2016 (32506)
2015 (37736)
2014 (30366)
2013 (26331)
2012 (27203)
2011 (27650)
2010 (25983)
Location
Africa (979)
Alabama (59)
Alaska (7)
Arizona (185)
Arkansas (14)
Asia (40639)
Australia (7367)
California (6119)
Canada (1978)
China (543)
Colorado (266)
Connecticut (282)
Delaware (148)
Europe (95158)
Florida (892)
Georgia (205)
Idaho (56)
Illinois (560)
India (28)
Indiana (288)
Iowa (12)
Japan (164)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (48)
Maryland (887)
Massachusetts (4746)
Michigan (219)
Minnesota (386)
Mississippi (1)
Missouri (81)
Montana (28)
Nebraska (22)
Nevada (56)
New Hampshire (61)
New Jersey (1731)
New Mexico (30)
New York (1759)
North Carolina (1018)
North Dakota (8)
Northern California (2656)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1365)
Puerto Rico (11)
Rhode Island (32)
South America (1277)
South Carolina (22)
South Dakota (1)
Southern California (2289)
Tennessee (83)
Texas (884)
United States (23219)
Utah (168)
Virginia (151)
Washington D.C. (62)
Washington State (570)
West Virginia (3)
Wisconsin (53)
686,115 Results for "the lupus research alliance".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research
April 16, 2025
·
7 min read
Press Releases
Lupus Research Alliance Grants Inaugural Awards to 11 Researchers Focused on Engineered Cell Therapies for Lupus
March 20, 2025
·
8 min read
Business
Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy
The Lupus Research Alliance announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The University of Tennessee Health Science Center, and Georg Schett, M.D., Friedrich-Alexander-Universität Erlangen-Nürnberg, for their groundbreaking discoveries in utilizing CAR T cell therapy to potentially revolutionize lupus treatment.
June 20, 2024
·
6 min read
Pharm Country
Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award
The Lupus Research Alliance is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award, whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus.
February 28, 2024
·
6 min read
Press Releases
Lupus Research Alliance Announces Lupus Research Highlights at ACR Convergence 2024
November 5, 2024
·
10 min read
Press Releases
Feinstein Institutes Researchers Lead Successful Study Demonstrating Benefit to Patients With Lupus Kidney Disease
April 21, 2025
·
2 min read
Press Releases
Feinstein Institutes awarded Lupus Research Alliance funding for vagus nerve stimulation clinical trial
November 7, 2024
·
4 min read
Press Releases
GI Alliance and Iterative Health Partner to Advance GI Clinical Research in the Community
April 23, 2025
·
3 min read
Pharm Country
Lupus Research Alliance and its Clinical Research Affiliate Lupus Therapeutics Launch the Lupus Landmark Study to Accelerate Personalized Treatments in Lupus
The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus.
May 23, 2023
·
5 min read
Business
Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery
Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics to support the development of the patient registry component of the Lupus Nexus, which aims to advance and accelerate lupus research and drug discovery through information exchange capabilities.
May 24, 2023
·
2 min read
1 of 68,612
Next
